Migraspirina (Acetylsalicylic Acid)

Acetylsalicylic acid works by irreversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins and thromboxane A2. This inhibition lowers the levels of these mediators, resulting in reduced pain, fever, inflammation, and decreased platelet clumping.

The appropriate dose of Migraspirina is determined by a qualified prescriber based on the specific indication, patient age, weight, and overall health status. Patients should follow the healthcare professional’s instructions and never adjust the dose on their own.

Safety of Migraspirina during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To order Migraspirina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Migraspirina contains the same active ingredient, acetylsalicylic acid, found in other aspirin brands, offering comparable analgesic, antipyretic, anti‑inflammatory and antiplatelet effects. Compared with non‑aspirin NSAIDs, it has a well‑characterised antiplatelet profile but shares similar gastrointestinal risk, making individual patient factors important when selecting therapy.

Migraspirina should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, direct sunlight and excessive heat to maintain product stability.

Migraspirina is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce the chance of stomach irritation. Patients should swallow tablets whole and not crush or chew them unless directed otherwise by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, hemorrhagic stroke, and, in children and teenagers with viral infections, the rare but potentially fatal Reye's syndrome. Prompt medical attention is required if any of these serious events are suspected.

Migraspirina should be avoided by individuals with a known hypersensitivity to aspirin or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe renal or hepatic impairment, and anyone who has experienced a previous severe allergic reaction to acetylsalicylic acid. Consultation with a healthcare professional is essential before use.